News

Company News

Industry News

Director Zhao Weidong, a doctoral supervisor of the Affiliated Hospital of the University of Science and Technology of China, an academic leader in the field of obstetrics and gynecology in Anhui

Director Zhao Weidong, a doctoral supervisor of the Affiliated Hospital of the University of Science and Technology of China, an academic leader in the field of obstetrics and gynecology in Anhui

On the afternoon of March 25, 2021, Zhao Weidong, the doctoral supervisor of the Affiliated Hospital of the University of Science and Technology of China and an academic leader in the field of obstetrics and gynecology in Anhui, and Li Tao, the director of the Provincial Women's Health Center, visited Huibang to guide the work and exchanged in-depth views on industry-university-research cooperation.

25

2021-03

Representatives of the two sessions called for: promoting early screening and early diagnosis of diabetic nephropathy, and improving the management level of major chronic diseases

Representatives of the two sessions called for: promoting early screening and early diagnosis of diabetic nephropathy, and improving the management level of major chronic diseases

There are more than 130 million diabetic patients in China. Diabetes is one of the public problems that seriously affect the health of Chinese people. The harm caused by complications of diabetes is not only related to the lives and health of the people

25

2021-03

Professor Fang Zhaohui and his entourage visited Huibang Biology for a visit and exchange

Professor Fang Zhaohui and his entourage visited Huibang Biology for a visit and exchange

On the afternoon of March 9, 2021, Professor Fang Zhaohui, a famous doctor from Jianghuai, director of Anhui Institute of Diabetes Prevention and Treatment of Traditional Chinese Medicine, and doctoral supervisor of Anhui University of Traditional Chinese Medicine, visited our company for visits, guidance and exchanges.

10

2021-03

Goddess' Day丨Huibang is beautiful because of you

Goddess' Day丨Huibang is beautiful because of you

In March of Yangchun, everything recovers, flowers bloom, and there is vitality everywhere. The spring of 2021 will come as promised on the east wind. In this March full of spring, full of poetry and vitality, we ushered in the 111th "March 8" International Women's Day!

08

2021-03

Huibang Biotech's

Huibang Biotech's "Planned Treatment for Premature Rupture of Membranes" was selected as one of the fifth batch of health and health appropriate technology promotion projects in the province

Recently, Huibang Biotech's "Planned Treatment for Premature Rupture of Membranes" was successfully selected into the fifth batch of health technology promotion projects in Anhui Province.

24

2021-02

To create an industrial chain, Huibang Biological will increase the research and development of IVD innovative products with its original ability, and continue to develop the raw material market

To create an industrial chain, Huibang Biological will increase the research and development of IVD innovative products with its original ability, and continue to develop the raw material market

Recently, Anhui Huibang Bioengineering Co., Ltd. (hereinafter referred to as "Huibang Bio") , an IVD manufacturer , announced the completion of the second strategic financing. This round of financing was jointly completed by Jiaxing Qihui and Saizhi Capital. The proceeds from the financing will be used to accelerate product development. Post-launch marketing.

28

2021-01

The journey is tens of thousands of miles, the wind is vigorous, and the heavy responsibility is imminent, and we will start again!

The journey is tens of thousands of miles, the wind is vigorous, and the heavy responsibility is imminent, and we will start again!

15

2021-01

Strong alliance and win-win development, Huibang Biotech completed the second round of strategic financing

Strong alliance and win-win development, Huibang Biotech completed the second round of strategic financing

On December 25, 2020, Huibang Biotechnology (Anhui Huibang Bioengineering Co., Ltd., referred to as "Huibang Biology") officially announced the completion of the second round of financing. The signing ceremony was held at the Management Committee of Hefei High-tech Zone. This round of financing was jointly completed by Jiaxing Qihui and Saizhi Capital, with an estimated market value of more than 300 million. It is worth mentioning that nine Huibang strategic partners and provincial agents from all over the country participated in the list of capital parties, which has added a strong guarantee to Huibang's take-off.

15

2021-01

< 123456 >